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Banti's Syndrome: Case Report and Review of Literature
S.N. Waqar,S.Jindhani,N. S. Baig,M. A. Waqar,F. W. Ismail,M. Tariq ( Department of Medicine, The Aga
Khan University )

Introduction
In 1898 Banti described a disorder characterized by splenomegaly and hypersplenism,
resulting in portal hypertension and anemia in the absence of hematological disease. 1
Banti's syndrome is also known as non-cirrhotic portal hypertension (NCPH) in India and
Idiopathic Portal Hypertension (IPH) in Japan. Hepatoportal sclerosis seems to be its
counterpart in the United States. 2,3 Banti's syndrome is a disorder of unknown etiology,
clinically characterized by portal hypertension (varices and portosystemic collateral
vessels), splenomegaly, and anemia (hypersplenism). 3 It has been reported from Indian
subcontinent. 4-6 In a Pakistani case series of portal hypertension, 18 out of 37 patients
were found to have IPH as the etiology. 6 We report a case of Banti's syndrome in an 20year old girl presenting to us with anemia and splenomegaly.
Case Report
A 20 year old female was referred to us for the evaluation of symptomatic anemia. She
also complained of longstanding dull, dragging left sided abdominal pain. Review of
systems revealed menorrhagia. On examination she was a lean, pale-looking girl. There
was no lymphadenopathy or icterus. She was afebrile, her vitals were stable and
cardiovascular examination revealed a systolic flow murmur in the mitral area. Her liver
was not palpable, however, she had massive splenomegaly with the splenic edge reaching
just below the umbilicus. Laboratory data revealed pancytopenia (Hb=8.4 gm/dl,
WBC=2200/mm3 with 67% PMN and 22% lymphocytes, Platelet = 35,000/mm3) and
peripheral blood film showed anisocytosis and hypochromic microcytic anemia. Her
coagulation profile was normal, as were her liver function tests. Anemia workup revealed
iron deficiency and five serial malarial parasite tests were negative. Coomb's test and
autoimmune profile were negative and hypercoagulable states were ruled out. Her
hepatitis serology was negative and she had normal [(0)]
ceruloplasmin and alpha-l antitrypsin levels. Her bone marrow revealed a cellular
specimen showing all hematopoeitic cell lines and massive splenomegaly was confIrmed
on CT Abdomen, which demonstrated a splenic size of 21.7 cm in cranio-caudal extent.
Moreover, it showed large varices in the splenic hilum, gastro-splenic and gastropancreatic ligaments and cavernous transformation of the portal vein, indicative of portal
hypertension (Figure 1 ). Her liver size and texture was normal on CT scan and there was
no evidence of cirrhosis (Figure 2). Ultrasound Color Doppler demonstrated numerous
patent collaterals resulting from this cavernous transformation, with a hepatoportal flow
velocity of 24 cm/sec. Esophagogastroduodenoscopy and sigmoidoscopy were normal. A
presumptive diagnosis of Banti's syndrome was made on the basis of pancytopenia,
splenomegaly and non cirrhotic portal hypertension. She was put on iron and folate
supplements. In addition, low dose propranolol was also started, to reduce portal

pressures. Splenectomy was not considered as she has no evidence of active bleeding.
Her blood counts improved on supportive medical management.
Discussion
Patients with Banti's syndrome may present with a long-standing mass in the left upper
quandrant due to splenomegaly and consequences of hypersplenism, as did our patient, or
they may present with one or more well- tolerated episodes of gastrointestinal variceal
bleeds resulting from portal hypertension. 7 Development of jaundice, hepatic
encephalopathy and ascites is uncommon and the liver function tests are preserved in
majority of patients. 7 ,8 Anemia in these patients may be microcytic, hypochromic due
to gastrointestinal blood loss or normocytic, normochromic due to hypersplenism. 7 Our
patient had microcytic hypochromic anemia despite normal endoscopy. Thalasemia was
ruled out by serum protein electrophoresis. Anemia in this patient could be multifactorial,
with menorrhagic blood loss and nutritional deficiency compounding hypersplenism.
Leukopenia (<4000/mm3) and thrombocytopenia (<50,000/mm3) may occur in these
patients on account of increase in plasma volume and splanchnic pooling of the blood
while the bone marrow is hypercellular. Symptomatic hypersplenism is rather rare and
necessitates intervention. 7 Banti's syndrome is a rare disease in the West, although its
incidence in other countries, such as Japan and India is relatively higher. 9 The condition
has been commonly seen in people who are socioeconomically disadvantaged, both in
India and Iran. 7,l0 Improved hygiene and standards of living could explain the relative
rarity of the disease in the West and its declining incidence in Japan, indirectly
suggesting a role of infection. 1 I The few studies done in the Indian subcontinent
indicate a male predominance in contrast to the West and Japan, where the disease is
more common in females. Furthermore it affects a much younger age group of patients,
varying from 25 to 35 years. 7 The etiology of Banti's syndrome is not well- understood.
A number of hypotheses have been proposed implicating the role of systemic or intraabdominal infections, relationship with hepatitis B virus, clotting abnormalities and
chronic exposure to toxic substances such as arsenic leading to phlebosclerosis of small
portal vessels. 7,12 Immunologic and immunogenetic hypotheses have also been
proposed, supported by reduction in suppressor/cytotoxic T lymphocytes and
predominant Th1 cells seen in this disorder. 7,13 The HLA-DR expression in portal
microvessels may be an initiating factor leading to immunologic assault on portal
microvessels. 14 Based on the above theories, Sarin et al. concluded that the disorder
could develop in a genetically predisposed individual when prothrombotic events
precipitated repeated microthrombotic insults in the small and medium branches of the
portal vein. The main histopathologic findings are periportal fibrosis, intimal thickening
of intrahepatic portal venous channels, obliteration of small portal venules and emergence
of new aberrant portal venous channels. Although these abnormalities could be secondary
to portal hypertension, it has been proposed that the vascular changes are the primary
event that leads to portal hypertension. 8 The intrasplenic and portal vein pressures are
markedly elevated in patients with Banti's syndrome, as are splenic and portal vein blood
flow, suggestive of hyperdynamic circulatory state. On ultrasonography, the portosplenic
axis is seen as dilated and patent, as was the case with our patient. Hepatic venography
and radionuclide scintigraphy have been used to distinguish between this entity and

cirrhosis. 6,7 CT portography and CT hepatic angiography have also been used to
demonstrate the aberrant vessels in these patients. The key management issues in patients
with Banti's are gastrointestinal hemorrhage and hypersplenism. For acutely bleeding
patients, endoscopic sclerotherapy and variceal ligation are equally efficacious in 95% of
patients and very few need to undergo emergency shunt surgery. Variceal recurrence has
been reported in approximately 20% of patients, though only 3% of these bleed
recurrently. Beta-blockers are efficacious in primary prophylaxis even in non-cirrhotic
patients with portal hypertension. 7 Surgery is also indicated for patients with
symptomatic hypersplenism -spontaneous bleeding episodes or severe anemia requiring
transfusion or repeated splenic infarcts. Prognosis for patients with Banti's disease is
excellent. Even in patients with acute variceal bleeds, the mortality is significantly lower
than seen in cirrhotic patients. After successful eradication of such gastroesophageal
varices, the 5-year survival is reported to be as high as 100%. 7
References
1. Banti G Splenomegalie mit Leberzirrhose Beitrage zur Pathologischen
AnatAllgemeinea Pathol 1889;24:21-33.
2. Tomikawa M, Yamaguchi, S, Sugimachi K. Idiopathic portal hypertension NipponRinsho 2002;60 (Suppl l):250-6.
3. Okudaira M, Ohbu M, Okuda K Idiopathic portal hypertension and its pathology
Semin Liver Dis 200222:59-72.
4. Datta DV Non-cirrhotic portal fibrosis ('idiopathic' portal hypertension in India). J
Assoc Physicians India 1976;24:511-27.
5. Makharia G, Dhiman RK, Chawla YK, et al. Non-cirrhotic portal fibrosis in a patient
with rheumatoid arthritis Indian J Gastroenterol 2001;20:197-8.
6. Qureshi H, Kamal S, Khan R.A, et al Differentiation of cirrhotic vs idiopathic portal
hypertension using 99rnTc-Sn colloid dynamic and static scintigraphy. J Pak MedAssoc
1991;411:26-9.
7. Sarin,SK, Kapoor D Non-cirrhotic portal fibrosis current concepts and management.
JGastroenterol Hepatol2002;17:526-34.
8. Dhiman R, Chawla Y, Vasishta R, et al. Non-cirrhotic portal fibrosis (idiopathic portal
hypertension) experience with 151 patients and a review of the literature. J Gastroenterol
Hepatol 2002;1:6-16.
9. Oikawa H, Masuda T, Sato S, et al Changes in lymph vessels and portal veins in the
portal tract of patients with idiopathic portal hypertension a morphometric study.
Hepatology 1998;27:1607-10.
10. Vakili C, Farahvash MJ, Bynum TE "Endemic" idiopathic portal hypertension. report
on 32 patients with non-cirrhotic portal fibrosis World-J Surg 1992;16:118-24.
11. Okudaira M, Ohbu M, Okuda K Idiopathic portal hypertension and its pathology
Semin Liver Dis 2002;22.59-72.
12. Orozco H, Takahashi T, Garcia-Tsao G, et al Idiopathic portal hypertension Rev
Invest Clin 1991;43.80-6.
13. Tokushige K, Yamauchi K, Komatsu T Predominant T helper I cells in patients with
idiopathic portal hypertension] Gastroenterol Hepatol 2000;15'1312-7.
14. Terada T, Nakanuma Y, Obata H HLA-DR expression on the microvasculature of

portal tracts in idiopathic portal hypertension Immunohistochemical characteristics and
relation to portal phlebosclerosis Arch Pathol Lab Med 1991; 115993-7.

